In the pivotal PULSAR and PHOTON trials, it was found to be as effective with either 12- or 16-week dosing as the original 2 mg Eylea formulation, which needs to be injected every eight weeks ...

In terms of study design itself, the PULSAR trial recruited treatment-naive patients with neovascular AMD, and these patients were randomly assigned 1:1:1 to EYLEA 2 mg given every 8 weeks, EYLEA 8 mg ...

TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) ...

Adults with chronic kidney disease and type 2 diabetes had slower kidney function decline with a combination of the and ...

Pharmacokinetic analysis showed that the CSF to free plasma osimertinib ratio was 22%. Most safety profiles were grade 1 and 2. Treatment with 80 mg once daily osimertinib achieved a median OS of 15.0 ...

An osteoanabolic agent should be the first choice treatment for patients at high or imminent risk for fracture, but once ...

For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have ...

IVMED-85 is a preservative-free, non-atropine daily drop that slows myopia progression by strengthening scleral and corneal ...

The data from the phase 2 PRISM study comes from a cohort of 51 ... a high treatment burden with an average of 10 injections with Eylea (aflibercept), a widely-used VEGF inhibitor sold by Bayer ...

A suspension of pantoprazole 2 mg/mL was prepared by triturating 20 40-mg tablets of pantoprazole,a mixing with sterile water for irrigationb and sodium bicarbonate,c and diluting to a final ...

When is the Hades 2 release date? The mythological roguelike game was revealed during The Game Awards 2022. Despite receiving critical praise for their previous titles, Hades 2 is the first sequel ...

An SGLT2 inhibitor combined with a nonsteroidal mineralocorticoid receptor antagonist quickly cut urinary ...